I cannot provide a meaningful professional summary of this article because the provided content does not contain substantive information, research findings, or announcements to summarize. The text is simply a brief introductory statement inviting vaccine-related questions to be submitted to the Los Angeles County Department of Public Health's Vaccine Preventable Disease Control Program, with a promise that submissions will be addressed by program members. There are no specific techniques, findings, figures, molecules, companies, or trials discussed. To produce an informative summary suitable for a professional intelligence platform, source material containing actual content, data, or newsworthy developments would be required.

Long COVID affects far more Americans than commonly recognized, with prevalence estimates ranging from 6.9% to 16% of the adult population, potentially representing 54 million people. While fatigue, brain fog, and respiratory symptoms dominate public discourse, emerging evidence reveals significant foot and lower extremity complications that remain poorly understood and undertreated. WeTreatFeet Podiatry has documented increasing cases of burning feet, aching, and swelling in Long COVID patients since 2020, patterns now validated by peer-reviewed research. The underlying mechanisms involve the SARS-CoV-2 spike protein, which remains biologically active even after acute infection resolves. Research published in Clinical Infectious Diseases in 2023 demonstrated circulating spike protein detectable in Long COVID patients months post-infection, indicating a persistent viral reservoir, likely in the gut, continuously releasing antigen into circulation. This persistent antigenic presence, combined with other cellular mechanisms, explains the varied, stubborn nature of foot symptoms resistant to conventional treatment approaches. Recognizing podiatric manifestations of Long COVID is critical for improving patient outcomes in this undertreated population.

Researchers led by Dr. Rachel Gross at New York University School of Medicine and Dr. Harrison Reeder at Harvard Medical School analyzed data from the NIH RECOVER pediatric cohort to examine how Long Covid affects school functioning in children aged 6–11 years and adolescents aged 12–17 years. The study encompassed approximately 400 children and 1,600 adolescents, with roughly one-third experiencing Long Covid. Children with Long Covid demonstrated approximately twice the risk of experiencing worse grades compared to peers without the condition, with about one in five reporting academic decline. They also faced 2.5 times higher risk of moderate to severe attention difficulties, affecting two in five affected children, and nearly three times higher risk of reduced peer enjoyment. Adolescents with Long Covid showed similarly concerning patterns, facing 2.5 times higher risk of grade decline, over three times higher risk of attention problems, and twice the risk of diminished social enjoyment. Both age groups with Long Covid were significantly more likely to require or be considered for special educational support services. This research, supported by Solve ME/CFS Initiative and led by prominent researchers including Drs. Akiko Iwasaki, Amy Proal, and Carmen Scheibenbogan, highlights Long Covid's substantial impact on pediatric academic and social development, extending understanding beyond pandemic-related isolation effects.

# Professional Summary Following COVID-19 infection, emerging clinical evidence demonstrates a significant association between the acute viral illness and the subsequent development of autoimmune manifestations in a subset of patients. This phenomenon reflects the complex interplay between viral pathogenesis and dysregulated immune responses, wherein SARS-CoV-2 infection can trigger or exacerbate underlying autoimmune conditions or precipitate newly diagnosed autoimmune diseases. The study examined documented cases of autoimmune manifestations emerging in the post-acute phase of COVID-19, analyzing the temporal relationship between viral infection and disease onset. Key findings indicate that molecular mimicry, bystander activation, and epitope spreading represent plausible mechanisms linking coronavirus infection to autoimmune activation. The research highlights diverse autoimmune presentations including rheumatological, hematological, and endocrinological disorders reported in COVID-19 survivors. This association carries substantial clinical implications for healthcare providers managing post-COVID patients, necessitating heightened surveillance for autoimmune symptoms and appropriate screening protocols. Understanding these immunopathological mechanisms is critical for developing preventive strategies and optimizing long-term management of affected individuals, particularly as the global burden of post-COVID sequelae continues to evolve.

This peer-reviewed article examines ten critical areas of COVID-19 policy, arguing that pandemic response strategies have often relied on preliminary data and have been slow to adapt as scientific evidence evolved. The authors conduct a comprehensive review of the latest evidence to reassess pandemic control measures in light of expanding vaccine rollouts and accumulated knowledge. The ten policy domains addressed include equitable vaccine distribution expansion, easing restrictions as hospitalization and mortality decline, prioritizing educational and harm reduction approaches over coercive measures, promoting outdoor activities, reopening schools, addressing the substantial economic and psychosocial consequences of prolonged lockdowns, eliminating ineffective surface disinfection protocols, reassessing testing policies, increasing access to outpatient therapies and prophylactics, and strengthening pandemic preparedness frameworks. The authors emphasize that while vaccines have proven remarkably effective, many underlying assumptions driving current policies warrant reevaluation based on contemporary evidence. This analysis is particularly timely as it challenges policymakers to recalibrate their COVID-19 response strategies with evolving scientific knowledge and real-world epidemiological trends.

This open-access case study, published in July 2026, examines the critical role of trust and historical experience in shaping public attitudes toward COVID-19 vaccination in Ghana. The research investigates how Ghanaian citizens' responses to vaccination campaigns are fundamentally influenced by their prior experiences with health interventions and their confidence in medical institutions. By analyzing these socio-historical factors, the study provides insights into vaccine hesitancy and acceptance patterns within a specific cultural and institutional context. The findings highlight that public health messaging and vaccination programs cannot ignore the legacy of past medical experiences, including historical instances of mistrust or inadequate healthcare provision. Understanding these determinants is essential for policymakers and health communicators seeking to improve vaccination uptake and build sustainable public health resilience. The research contributes valuable context-specific knowledge for designing culturally sensitive interventions that address underlying concerns and strengthen community engagement in disease prevention efforts.

Alzheimer's Disease remains the leading cause of dementia globally, affecting over 55 million individuals. While classical research has focused on amyloid-β and tau accumulation, emerging evidence suggests that neuroimmune dysregulation plays a critical role in early disease development, particularly during preclinical stages. Age-associated immune remodeling, including T-cell exhaustion and impaired antigen presentation, disrupts central nervous system immune surveillance. Dysregulated signaling through immune checkpoint molecules such as Programmed Cell Death Protein 1 and Cytotoxic T-Lymphocyte Associated Protein 4 may influence microglial activation, peripheral immune infiltration, and neuroinflammatory cascades preceding neurodegeneration. Advanced biomarker technologies including cerebrospinal fluid immune profiling, peripheral immunophenotyping, and molecular neuroimaging are revealing measurable neuroimmune signatures in early disease states. However, challenges remain regarding biomarker specificity and implementation across diverse healthcare systems. This review proposes that understanding neuroimmune dysfunction as a trackable component of AD pathogenesis could enable early risk stratification and preventative interventions, integrating insights from immunology, neuroscience, and public health research to address this critical public health challenge.

Long COVID presents a complex post-viral syndrome affecting multiple biological systems simultaneously, defying traditional medical categorization as neither an ongoing infection nor a psychiatric condition. Clear Health Centers in Salt Lake City addresses this challenge through a holistic therapeutic framework that moves beyond conventional specialty-based medicine. Rather than routing individual symptoms to separate specialists, the clinic employs comprehensive multi-system evaluation and advanced testing targeting mechanisms below standard diagnostic thresholds, including cytokine profiles, viral reactivation titers, mitochondrial function markers, autonomic assessments, and gut health evaluation. This approach recognizes that most significant Long COVID cases involve multiple concurrent biological processes. Standard laboratory panels often appear normal despite substantial pathology, necessitating specialized marker analysis. The clinic's treatment protocol is sequenced and layered, addressing biological drivers of persistent symptoms rather than managing them in isolation. Clinical evaluation incorporates detailed symptom timelines mapping when acute infection occurred and tracking symptom onset, constancy, fluctuation, and recovery patterns. This comprehensive diagnostic framework enables targeted intervention strategies that account for the interconnected nature of Long COVID pathophysiology, offering patients appropriate care for a condition that conventional medical models inadequately serve.

A prospective cross-sectional study reveals that persistent ocular symptoms (POS) affect a substantial portion of non-hospitalized COVID-19 survivors, lasting from three months to three years post-infection. Using symptom assessments, clinical examinations, and biofluid proteomics, researchers identified POS manifestations including near vision disturbances, strabismus, weakened pupillary reflexes, corneal neurodegeneration, and chronic immune cell activation on the ocular surface. Proteomic analysis identified dysregulated proteins including ITGB6, NFASC, CTGF, TPSAB1, and CKMT1A-CKMT1B, with elevated JUN correlating to pupil dysfunction and increased ANGPTL2, SKAP2, and DAPP1 levels associated with dendritic and T cell dysregulation. The findings implicate chronic T cell-mediated neuroinflammation in POS pathogenesis, characterized by strabismus, ocular dysautonomia, and peripheral ocular neuropathy. Diagnostic models combining clinical examination with biomarkers achieved 77-91% accuracy in predicting POS. These results address a significant gap in understanding long-COVID sequelae, as up to 35% of severe COVID-19 patients experience ocular symptoms, yet lack established diagnostic criteria and biomarkers, hindering recognition and clinical management of this debilitating syndrome.

A prospective cross-sectional study reveals that persistent ocular symptoms following COVID-19 affect non-hospitalized individuals for up to three years post-infection, causing significant vision disability. Beyond routine clinical findings, patients experience near vision disturbances, strabismus, corneal neurodegeneration, and weakened pupillary reflexes. Proteomic analysis of tear fluid identifies chronic T cell dysregulation and elevated inflammatory markers including ITGB6, NFASC, and ANGPTL2. Diagnostic models incorporating clinical examinations and biomarkers predict persistent ocular symptoms with 77-91% accuracy, implicating chronic T cell-mediated neuroinflammation as the underlying mechanism. These findings establish post-COVID ocular syndrome as a debilitating long-term sequela characterized by neuroinflammatory changes in ocular surface tissues and autonomic dysfunction.

Public health systems across the United States, United Kingdom, and European Union face significant infrastructural and epistemic crises, exemplified by debates surrounding the 2026 US childhood vaccination recommendations. Vaccination has become a focal point for political weaponization of scientific uncertainty, revealing deeper structural issues beyond external attacks on science or misinformation. Formal hierarchies of evidence, particularly the dominance of randomized controlled trials and quantification, narrow what constitutes legitimate knowledge in public health. While these approaches enhance rigor and accountability, they marginalize contextual, experiential, and social evidence. This epistemic limitation creates vulnerabilities that political actors exploit to amplify uncertainty and undermine collective health interventions. Addressing this crisis requires more than defending science; it demands rebuilding social, institutional, and epistemic foundations for evidence production. Interdisciplinary collaboration and meaningful community engagement are essential for developing plural, reflexive, and socially grounded evidence to sustain public health as a collective endeavor.

A comprehensive review of the billions of COVID-19 vaccine doses made with mRNA technology shows that these vaccines are safe and effective.

COVID-19 is associated with an increased, of new-onset autoimmune disease, most reproducibly affecting connective tissue, COVID-19 cohort showed markedly ...

The computational workflow developed in this study enables the identification and prioritization of candidate HLA-DRB5*01:01-restricted CD4+ T-cell epitopes ...

RNA therapeutics manufacturing is undergoing a transformative shift from batch-based to continuous processing systems, powered by artificial intelligence and advanced automation. The industry is moving beyond achieving scale to focus on reducing costs, improving accessibility, and enabling personalized therapies. Manufacturers are investing in continuous processing workflows that integrate synthesis, purification, and formulation into streamlined operations, alongside next-generation RNA platforms such as self-amplifying RNA and circular RNA. These integrated technologies create more stable production kinetics, reduce manufacturing inefficiencies, and enable real-time quality monitoring. This evolution represents a broader industry trend toward adaptive, data-driven, and decentralized biomanufacturing ecosystems that promise significant improvements in production efficiency and therapeutic accessibility.

It is accompanied by post-exertional symptom exacerbation and non-restorative sleep. Fatigue is often disabling and reduces daily activity by more than 50 ...

1.In Vitro Transcription (IVT): Reaction system comprises ... mRNA Purification: Captures full-length target mRNA and eliminates dsRNA contaminants.

This research article examines the efficacy of second-generation COVID-19 vaccines administered during pregnancy. The study evaluates immunological responses and protective outcomes for both pregnant individuals and their newborns following vaccination with updated vaccine formulations. The findings contribute to understanding vaccine safety and effectiveness in this vulnerable population, providing evidence to inform clinical guidelines for prenatal immunization strategies. The research addresses critical gaps in maternal-fetal health data, supporting informed decision-making for healthcare providers and expectant mothers regarding COVID-19 vaccination during gestation.

In vitro transcription (IVT) has emerged as the critical manufacturing platform for mRNA-based therapeutics, spanning vaccines, immunotherapies, and gene editing applications. However, conventional lab-scale synthesis faces significant technical hurdles including residual double-stranded RNA, endotoxin contamination, compromised RNA integrity, and inconsistent batch performance. These impurities trigger undesired immune responses and impair translational efficacy. This article addresses standardized IVT workflows, quality control specifications, and analytical validation systems essential for robust preclinical research. It examines key contaminants—immunostimulatory dsRNA, endotoxin residues, and structural defects—and demonstrates how optimized platforms with integrated purification strategies and systematic quality monitoring support reproducible, high-performance mRNA production.

A major study determines that autoimmunity is causing major symptoms in long COVID ultimately laying the groundwork for precision-guided treatments.